vs

Side-by-side financial comparison of Axos Financial, Inc. (AX) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

Axos Financial, Inc. is the larger business by last-quarter revenue ($392.2M vs $197.9M, roughly 2.0× REPLIGEN CORP). Axos Financial, Inc. runs the higher net margin — 31.8% vs 6.7%, a 25.1% gap on every dollar of revenue. Over the past eight quarters, Axos Financial, Inc.'s revenue compounded faster (16.1% CAGR vs 14.4%).

Axos Financial is an American bank holding company based in Las Vegas, Nevada and is the parent of Axos Bank, a direct bank. It also offers registered investment adviser services and an electronic trading platform.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

AX vs RGEN — Head-to-Head

Bigger by revenue
AX
AX
2.0× larger
AX
$392.2M
$197.9M
RGEN
Higher net margin
AX
AX
25.1% more per $
AX
31.8%
6.7%
RGEN
Faster 2-yr revenue CAGR
AX
AX
Annualised
AX
16.1%
14.4%
RGEN

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
AX
AX
RGEN
RGEN
Revenue
$392.2M
$197.9M
Net Profit
$124.7M
$13.3M
Gross Margin
52.5%
Operating Margin
9.0%
Net Margin
31.8%
6.7%
Revenue YoY
13.6%
Net Profit YoY
18.5%
143.9%
EPS (diluted)
$2.15
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AX
AX
RGEN
RGEN
Q1 26
$392.2M
Q4 25
$385.1M
$197.9M
Q3 25
$323.4M
$188.8M
Q2 25
$321.4M
$182.4M
Q1 25
$308.8M
$169.2M
Q4 24
$307.9M
$174.1M
Q3 24
$320.7M
$154.9M
Q2 24
$290.9M
$154.1M
Net Profit
AX
AX
RGEN
RGEN
Q1 26
$124.7M
Q4 25
$128.4M
$13.3M
Q3 25
$112.4M
$14.9M
Q2 25
$110.7M
$14.9M
Q1 25
$105.2M
$5.8M
Q4 24
$104.7M
$-30.3M
Q3 24
$112.3M
$-654.0K
Q2 24
$104.9M
$3.3M
Gross Margin
AX
AX
RGEN
RGEN
Q1 26
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Operating Margin
AX
AX
RGEN
RGEN
Q1 26
Q4 25
45.6%
9.0%
Q3 25
46.3%
8.9%
Q2 25
48.5%
7.6%
Q1 25
47.9%
3.9%
Q4 24
48.8%
-17.7%
Q3 24
49.6%
-5.1%
Q2 24
49.6%
1.0%
Net Margin
AX
AX
RGEN
RGEN
Q1 26
31.8%
Q4 25
33.3%
6.7%
Q3 25
34.7%
7.9%
Q2 25
34.4%
8.2%
Q1 25
34.1%
3.4%
Q4 24
34.0%
-17.4%
Q3 24
35.0%
-0.4%
Q2 24
36.0%
2.2%
EPS (diluted)
AX
AX
RGEN
RGEN
Q1 26
$2.15
Q4 25
$2.22
$0.24
Q3 25
$1.94
$0.26
Q2 25
$1.89
$0.26
Q1 25
$1.81
$0.10
Q4 24
$1.80
$-0.55
Q3 24
$1.93
$-0.01
Q2 24
$1.75
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AX
AX
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$3.1B
$2.1B
Total Assets
$29.2B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AX
AX
RGEN
RGEN
Q1 26
Q4 25
$1.0B
$767.6M
Q3 25
$2.6B
$748.7M
Q2 25
$1.9B
$708.9M
Q1 25
$2.0B
$697.2M
Q4 24
$2.4B
$757.4M
Q3 24
$2.6B
$784.0M
Q2 24
$2.0B
$809.1M
Total Debt
AX
AX
RGEN
RGEN
Q1 26
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
$312.7M
Q1 25
$377.4M
Q4 24
$358.7M
$525.6M
Q3 24
$313.5M
Q2 24
$325.7M
Stockholders' Equity
AX
AX
RGEN
RGEN
Q1 26
$3.1B
Q4 25
$2.9B
$2.1B
Q3 25
$2.8B
$2.1B
Q2 25
$2.7B
$2.1B
Q1 25
$2.6B
$2.0B
Q4 24
$2.5B
$2.0B
Q3 24
$2.4B
$2.0B
Q2 24
$2.3B
$2.0B
Total Assets
AX
AX
RGEN
RGEN
Q1 26
$29.2B
Q4 25
$28.2B
$2.9B
Q3 25
$27.4B
$2.9B
Q2 25
$24.8B
$2.9B
Q1 25
$24.0B
$2.9B
Q4 24
$23.7B
$2.8B
Q3 24
$23.6B
$2.8B
Q2 24
$22.9B
$2.9B
Debt / Equity
AX
AX
RGEN
RGEN
Q1 26
Q4 25
0.26×
Q3 25
0.26×
Q2 25
0.12×
Q1 25
0.14×
Q4 24
0.14×
0.27×
Q3 24
0.13×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AX
AX
RGEN
RGEN
Operating Cash FlowLast quarter
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AX
AX
RGEN
RGEN
Q1 26
Q4 25
$104.1M
$25.7M
Q3 25
$118.4M
$48.1M
Q2 25
$490.3M
$28.6M
Q1 25
$73.7M
$15.0M
Q4 24
$162.5M
$39.2M
Q3 24
$70.8M
$49.3M
Q2 24
$305.5M
$42.2M
Free Cash Flow
AX
AX
RGEN
RGEN
Q1 26
Q4 25
$85.4M
$17.6M
Q3 25
$109.3M
$43.4M
Q2 25
$436.1M
$21.5M
Q1 25
$65.1M
$11.4M
Q4 24
$156.4M
$33.6M
Q3 24
$53.0M
$42.3M
Q2 24
$269.5M
$37.4M
FCF Margin
AX
AX
RGEN
RGEN
Q1 26
Q4 25
22.2%
8.9%
Q3 25
33.8%
23.0%
Q2 25
135.7%
11.8%
Q1 25
21.1%
6.8%
Q4 24
50.8%
19.3%
Q3 24
16.5%
27.3%
Q2 24
92.6%
24.3%
Capex Intensity
AX
AX
RGEN
RGEN
Q1 26
Q4 25
4.9%
4.1%
Q3 25
2.8%
2.5%
Q2 25
16.9%
3.9%
Q1 25
2.8%
2.1%
Q4 24
2.0%
3.2%
Q3 24
5.5%
4.5%
Q2 24
12.4%
3.1%
Cash Conversion
AX
AX
RGEN
RGEN
Q1 26
Q4 25
0.81×
1.93×
Q3 25
1.05×
3.23×
Q2 25
4.43×
1.92×
Q1 25
0.70×
2.57×
Q4 24
1.55×
Q3 24
0.63×
Q2 24
2.91×
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AX
AX

Net Interest Income$306.3M78%
Noninterest Income$86.0M22%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons